IR@PKUHSC  > 北京大学第一临床医学院  > 心血管内科
学科主题临床医学
A Systematic Literature Review of Risk Factors for Stroke in China
Yong, Huo1; Foody, JoAnne2; Ji Linong3; Dong, Zhao4; Wang, Yongjun5; Ma, Li6; Meng, Hai Jin7; Shiff, Susan8; Dayi, Hu9,10
关键词stroke risk factors smoking diabetes hypertension dyslipidemia obesity
刊名CARDIOLOGY IN REVIEW
2013-03-01
DOI10.1097/CRD.0b013e3182748d37
21期:2页:77-93
收录类别SCI
文章类型Review
WOS标题词Science & Technology
类目[WOS]Cardiac & Cardiovascular Systems
资助者Pfizer Inc. Emerging Markets Outcomes Research and Epidemiology ; Pfizer Inc. ; Pfizer Inc. Emerging Markets Outcomes Research and Epidemiology ; Pfizer Inc.
研究领域[WOS]Cardiovascular System & Cardiology
关键词[WOS]REPUBLIC-OF-CHINA ; ISCHEMIC-STROKE ; HEMORRHAGIC STROKE ; HAN POPULATION ; METABOLIC SYNDROME ; BLOOD-PRESSURE ; UNITED-STATES ; HEALTH SURVEY ; FOLLOW-UP ; HYPERTENSION
英文摘要

Other countries have seen a decline in stroke incidence after improved treatment and prevention of known risk factors for stroke. China is still experiencing significant increases in the incidence rate of total stroke. We systematically reviewed the evidence on the impact of 5 modifiable risk factors (hypertension, dyslipidemia, obesity, diabetes, and smoking) for the risk of stroke in the Chinese population, with the aim to develop more effective prevention and disease management programs. A literature search was conducted in MEDLINE and EMBASE for all observational studies that reported on the association between risk of stroke and any of the 5 risk factors and the composite risk factor. Selected articles were published in either English or Chinese from January 2004 to December 2010. Evidence of the association between hypertension and stroke was the strongest of the 5 factors reported in studies, with adjusted odds ratios ranging between 2.75 and 5.47. The association among obesity, diabetes, smoking, and the risk for stroke was evident, but not as strong as for hypertension. The risk ratios of hypertension to stroke were higher in the Chinese population than those in other countries.

语种英语
资助者Pfizer Inc. Emerging Markets Outcomes Research and Epidemiology ; Pfizer Inc. ; Pfizer Inc. Emerging Markets Outcomes Research and Epidemiology ; Pfizer Inc.
WOS记录号WOS:000315046500002
引用统计
被引频次:22[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/62598
专题北京大学第一临床医学院_心血管内科
作者单位1.United BioSource Corp, Bethesda, MD USA
2.Pfizer Investment Co Ltd, Beijing, Peoples R China
3.Pfizer Inc, New York, NY 10017 USA
4.Chinese Soc Cardiol, Beijing, Peoples R China
5.Peking Univ, Hosp 1, Dept Cardiol, Beijing 100871, Peoples R China
6.Brigham & Womens Hosp, Cardiovasc Wellness Program, Boston, MA 02115 USA
7.Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China
8.Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing An Zhen Hosp, Dept Epidemiol, Beijing, Peoples R China
9.Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
10.Peking Univ, People Hosp, Ctr Heart, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Yong, Huo,Foody, JoAnne,Ji Linong,et al. A Systematic Literature Review of Risk Factors for Stroke in China[J]. CARDIOLOGY IN REVIEW,2013,21(2):77-93.
APA Yong, Huo.,Foody, JoAnne.,Ji Linong.,Dong, Zhao.,Wang, Yongjun.,...&Dayi, Hu.(2013).A Systematic Literature Review of Risk Factors for Stroke in China.CARDIOLOGY IN REVIEW,21(2),77-93.
MLA Yong, Huo,et al."A Systematic Literature Review of Risk Factors for Stroke in China".CARDIOLOGY IN REVIEW 21.2(2013):77-93.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yong, Huo]的文章
[Foody, JoAnne]的文章
[Ji Linong]的文章
百度学术
百度学术中相似的文章
[Yong, Huo]的文章
[Foody, JoAnne]的文章
[Ji Linong]的文章
必应学术
必应学术中相似的文章
[Yong, Huo]的文章
[Foody, JoAnne]的文章
[Ji Linong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。